🔎 Trials Near Me

Home › Blastic Plasmacytoid Dendritic Cell Cancer

Blastic Plasmacytoid Dendritic Cell Cancer clinical trials recruiting in the U.S.

8 studies for Blastic Plasmacytoid Dendritic Cell Cancer are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT04216524

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry

RecruitingObservational study
All ages · All sexes · Updated Jun 5, 2026 · NCT05430971

CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)

RecruitingPhase 1
Up to age 21 · All sexes · Updated May 19, 2026 · NCT04318678

Q702 for the Treatment of Patients With Hematologic Malignancies

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 10, 2025 · NCT06712810

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

RecruitingPhase 1
Ages 1 to 21 · All sexes · Updated Dec 6, 2024 · NCT05476770

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.